Keyphrases
Immune Checkpoint Molecules
97%
Programmed Death-ligand 1 (PD-L1)
97%
Wilms Tumor
97%
Tumor mutation Burden
97%
Matrix Effect
65%
Free Light Chain Assay
65%
Free Light Chains
65%
Colorectal Cancer
54%
Combined Positive Score
48%
Benign Tissue
43%
Malignant Tissue
43%
Human Colon
39%
High Prevalence
36%
Enterochromaffin-like Cell Hyperplasia
32%
Gastric Neuroendocrine Tumors
32%
Proton Pump Inhibitors
32%
Desmoplastic Ameloblastoma
32%
Ameloblastoma
32%
Pakistan
32%
Rheumatoid Arthritis
32%
Management Strategy
32%
Clinical Management
32%
Malignant Transformation
32%
Tertiary Care Hospital
32%
Clinical Features
32%
Squamous Cell Carcinoma (SqCC)
32%
Acoustic Resolution Photoacoustic Microscopy
32%
Acoustic Resolution
32%
Colon Pathology
32%
Spatial Heterogeneity
32%
Robotic Partial Nephrectomy
32%
Large-for-gestational-age
32%
Modulated Imaging
32%
Lymphocyte Infiltration
32%
Neoadjuvant
32%
Total Hemoglobin
32%
Photoacoustic Imaging
32%
Pregestational Diabetes
32%
Angular Spectrum
32%
Coefficient Maps
32%
Pathologic
32%
Scattering Coefficient
32%
Ultrasound
32%
Placenta
32%
Androgen Receptor
32%
Adherent Perinephric Fat
32%
Gallbladder
32%
Clinicopathologic Correlation
32%
Spatial Frequency Domain Imaging
32%
Inertia
32%
Medicine and Dentistry
CD8 Antigen
100%
Immunity
97%
Wilms' Tumor
97%
Programmed Death-Ligand 1
97%
Tumor Mutation Burden
97%
Neoplasm
91%
Colorectal Carcinoma
65%
Light Chain
65%
Ex Vivo
62%
Immune Checkpoint Inhibitor
58%
Lymphocyte
44%
Immunohistochemistry
44%
Colon
43%
Colon Tissue
40%
DNA Mismatch Repair
39%
Anaplastic Carcinoma
39%
Prevalence
36%
Enterochromaffin Like Cell
32%
Proton-Pump Inhibitor
32%
Cell Hyperplasia
32%
Neuroendocrine Tumor
32%
Squamous Cell Carcinoma
32%
Malignant Transformation
32%
Ameloblastoma
32%
Diabetes
32%
Photoacoustic Imaging
32%
Biopsy Technique
32%
Large for Gestational Age
32%
Placenta
32%
Ganglion
32%
Partial Nephrectomy
32%
Dysplasia
32%
Rectum Carcinoma
32%
Treatment Response
32%
Androgen Receptor
32%
Estrogen Receptor
32%
Progesterone Receptor
32%
Surgery
27%
T Lymphocyte
27%
Hormone Receptor
26%
Photoacoustic Microscopy
24%
Neoadjuvant Therapy
21%
Malignant Neoplasm
21%
Kidney Tumour
19%
Progression Free Survival
19%
Mismatch Repair Protein
19%
Receptor Expression
19%
Clear Cell Renal Cell Carcinoma
19%
B Lymphocyte
16%
Overall Survival
16%